{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:27:11Z","timestamp":1782818831527,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T00:00:00Z","timestamp":1639872000000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ethiopia, being in the Sub Saharan region of Africa, is one of the countries with a substantial burden of HIV infection. Because of the high burden of HIV and poor health care settings, HAND is prevalent as demonstrated in various cross-sectional studies. However, no review has been conducted to report the consolidated magnitude of HAND among people with HIV in Ethiopia. Therefore, this systematic review and meta-analysis aimed to estimate the prevalence of HAND in Ethiopia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Following the PRISMA guidelines, we systematically reviewed and meta-analyzed studies that investigated the prevalence of HAND in Ethiopia from PubMed, Google Scholar, Science Direct, HINARI, EMBASE, and Cochrane library databases. We also looked at the reference lists of the included studies to include other relevant studies. Subgroup analysis was performed based on publication year, study location, and sample size. Heterogeneity across studies was evaluated using the I2 test. Potential publication bias was assessed using Egger\u2019s test and visual inspection of symmetry in the funnel plots.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the present meta-analysis, 627 articles were initially identified and evaluated. Of these, 8 studies that met the inclusion criteria were included in the final analysis. The pooled prevalence of HAND in people with HIV in Ethiopia was 39.15% (95% CI 29.36, 48.94). The highest prevalence observed in the Southern Nations, Nationalities, and Peoples\u2019 Region (SNNPR) with 53.20% (95% CI 25.96, 80.44) followed by others 34.87% (Tigray, Addis Ababa, and Oromia) (95% CI 33.49, 36.24) and Amhara 34.07% (95% CI 25.39, 42.74).The funnel plot was asymmetrical. However, Egger\u2019s regression tests provided no evidence of publication bias in the prevalence of HAND.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this meta-analysis, the pooled prevalence of HAND, in Ethiopia, was high. Older age, substance use, advanced stages of the disease, and lack of education were the main determinants of HAND in Ethiopia. Health education, early screening of people with HIV, and training of health professionals working in hospitals on HAND are highly recommended.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-021-00424-1","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T07:02:23Z","timestamp":1639897343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A systematic review and meta-analysis of HIV associated neurocognitive disorders (HAND) among people with HIV in Ethiopia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-6588","authenticated-orcid":false,"given":"Yosef","family":"Zenebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baye","family":"Akele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulugeta","family":"W\/Selassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogesie","family":"Necho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,19]]},"reference":[{"issue":"2","key":"424_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/13550280390194109","volume":"9","author":"JC McArthur","year":"2003","unstructured":"McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, et al. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003;9(2):205\u201321.","journal-title":"J Neurovirol"},{"key":"424_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/S1355617700000230","volume":"1","author":"R Heaton","year":"1995","unstructured":"Heaton R, Grant I, Butters N, White D, Kirson D, Atkinson J, Abramson, & I., the HNRC Group, et al. The HNRC 500: neuropsychology of HIV-1 infection at different disease stages. J Int Neuropsychol Soc. 1995;1:231\u201351.","journal-title":"J Int Neuropsychol Soc"},{"issue":"9","key":"424_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/00002030-199009000-00025","volume":"4","author":"WH Organization","year":"1990","unstructured":"Organization WH. World Health Organization consultation on the neuropsychiatric aspects of HIV-1 infection. AIDS. 1990;4(9):935\u20136.","journal-title":"AIDS"},{"issue":"18","key":"424_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789\u201399.","journal-title":"Neurology"},{"issue":"4","key":"424_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, et al. HIV-associated neurocognitive disorder\u2014pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12(4):234\u201348.","journal-title":"Nat Rev Neurol"},{"key":"424_CR6","unstructured":"Clifford DB. HIV-associated neurocognitive disorders: epidemiology, clinical manifestations, and diagnosis. Uptodate Retrieved January. 2020;10:2021."},{"issue":"4","key":"424_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/ijms17040434","volume":"17","author":"E Foc\u00e0","year":"2016","unstructured":"Foc\u00e0 E, Magro P, Motta D, Compostella S, Casari S, Bonito A, et al. Screening for neurocognitive impairment in HIV-infected individuals at first contact after HIV diagnosis: the experience of a large clinical center in Northern Italy. Int J Mol Sci. 2016;17(4):434.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"424_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-7-8","volume":"7","author":"KR Robertson","year":"2007","unstructured":"Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, Parsons TD, et al. Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol. 2007;7(1):1\u20137.","journal-title":"BMC Neurol"},{"issue":"Suppl 1","key":"424_CR9","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1097\/00002030-200418001-00004","volume":"18","author":"CH Hinkin","year":"2004","unstructured":"Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (London, England). 2004;18(Suppl 1):S19.","journal-title":"AIDS (London, England)"},{"issue":"10","key":"424_CR10","doi-asserted-by":"publisher","first-page":"e820","DOI":"10.1016\/j.ijid.2013.06.011","volume":"17","author":"AG Habib","year":"2013","unstructured":"Habib AG, Yakasai AM, Owolabi LF, Ibrahim A, Habib ZG, Gudaji M, et al. Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis. 2013;17(10):e820\u201331.","journal-title":"Int J Infect Dis"},{"key":"424_CR11","unstructured":"Araya T, Abebaw D, Belete A, Derajew H, Umer H. Prevalence and factors associated with neuro cognitive disorders among HIV-positive patients in Ethiopia: a hospital-based cross-sectional study. Ethiopian J Health Dev. 2020;34(1)."},{"issue":"1","key":"424_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4314\/ejhs.v27i1.9","volume":"27","author":"T Belete","year":"2017","unstructured":"Belete T, Medfu G, Yemiyamrew E. Prevalence of HIV associated neurocognitive deficit among HIV positive people in Ethiopia: a cross sectional study at Ayder Referral Hospital. Ethiop J Health Sci. 2017;27(1):67\u201376.","journal-title":"Ethiop J Health Sci"},{"key":"424_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fpubh.2014.00105","volume":"2","author":"JM Attonito","year":"2014","unstructured":"Attonito JM, D\u00e9vieux JG, Lerner BD, Rosenberg R. Exploring substance use and HIV treatment factors associated with neurocognitive impairment among people living with HIV\/AIDS. Front Public Health. 2014;2:105.","journal-title":"Front Public Health"},{"issue":"5","key":"424_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/JNN.0000000000000074","volume":"46","author":"DE Vance","year":"2014","unstructured":"Vance DE, Fazeli PL, Dodson JE, Ackerman M, Talley M, Appel SJ. The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research. J Neurosci Nurs. 2014;46(5):292.","journal-title":"J Neurosci Nurs"},{"key":"424_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.11648\/j.ajpn.20140202.11","volume":"2","author":"TB Mossie","year":"2014","unstructured":"Mossie TB, Tegegne MT. HIV dementia among HIV positive people at Debre markos hospital, Northwest Ethiopia. Am J Psychol Neurosci. 2014;2:18\u201324.","journal-title":"Am J Psychol Neurosci"},{"issue":"01","key":"424_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/nm.2016.71001","volume":"7","author":"M Pascal","year":"2016","unstructured":"Pascal M, Gaspard T, Philom\u00e8ne N-K, Emmanuel Y, Avilah A-WP, Hortense H. Determinants of neurocognitive impairment in HIV in a cohort of patients on antiretroviral therapy followed in Bangui (Central African Republic). Neurosci Med. 2016;7(01):1.","journal-title":"Neurosci Med."},{"issue":"20","key":"424_CR17","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1212\/WNL.0000000000000433","volume":"82","author":"JF Sumowski","year":"2014","unstructured":"Sumowski JF, Rocca MA, Leavitt VM, Dackovic J, Mesaros S, Drulovic J, et al. Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS. Neurology. 2014;82(20):1776\u201383.","journal-title":"Neurology"},{"key":"424_CR18","first-page":"35","volume":"7","author":"CC Watkins","year":"2015","unstructured":"Watkins CC, Treisman GJ. Cognitive impairment in patients with AIDS\u2013prevalence and severity. Hiv\/aids (Auckland, NZ). 2015;7:35.","journal-title":"Hiv\/aids (Auckland, NZ)"},{"issue":"4","key":"424_CR19","first-page":"187","volume":"1","author":"NT Wabel","year":"2011","unstructured":"Wabel NT. Psychopharmacological aspects of catha edulis (khat) and consequences of long term use: a review. Psychiatry Behav Sci. 2011;1(4):187.","journal-title":"Psychiatry Behav Sci"},{"issue":"2","key":"424_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/hiv.12979","volume":"22","author":"M Sanmart\u00ed","year":"2021","unstructured":"Sanmart\u00ed M, Meyer A, Jaen A, Robertson K, Tan N, Mapesi H, et al. HIV-associated neurocognitive impairment in stable people living with HIV on ART in rural Tanzania. HIV Med. 2021;22(2):102\u201312.","journal-title":"HIV Med"},{"issue":"3","key":"424_CR21","doi-asserted-by":"publisher","first-page":"e0204636","DOI":"10.1371\/journal.pone.0204636","volume":"14","author":"M Debalkie Animut","year":"2019","unstructured":"Debalkie Animut M, Sorrie MB, Birhanu YW, Teshale MY. High prevalence of neurocognitive disorders observed among adult people living with HIV\/AIDS in Southern Ethiopia: a cross-sectional study. PLoS ONE. 2019;14(3):e0204636.","journal-title":"PLoS ONE"},{"issue":"10","key":"424_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1\u201334.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"424_CR23","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1080\/09540121.2013.763894","volume":"25","author":"JG D\u00e9vieux","year":"2013","unstructured":"D\u00e9vieux JG, Malow RM, Attonito JM, Jean-Gilles M, Rosenberg R, Gaston S, et al. Post-traumatic stress disorder symptomatology and alcohol use among HIV-seropositive adults in Haiti. AIDS Care. 2013;25(10):1210\u20138.","journal-title":"AIDS Care"},{"key":"424_CR24","volume-title":"Comprehensive meta-analysis","author":"M Bornstein","year":"2005","unstructured":"Bornstein M, Hedges L, Higgins J, Rothstein H. Comprehensive meta-analysis. Englewood: Biostat; 2005."},{"issue":"2","key":"424_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synthesis Methods. 2010;1(2):97\u2013111.","journal-title":"Res Synthesis Methods"},{"issue":"7414","key":"424_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"424_CR27","doi-asserted-by":"publisher","first-page":"102775","DOI":"10.1016\/j.nicl.2021.102775","volume":"31","author":"M Schantell","year":"2021","unstructured":"Schantell M, Taylor BK, Lew BJ, O\u2019Neill JL, May PE, Swindells S, et al. Gray matter volumes discriminate cognitively impaired and unimpaired people with HIV. NeuroImage Clin. 2021;31:102775.","journal-title":"NeuroImage Clin."},{"key":"424_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpsychires.2016.10.016","volume":"85","author":"M Tsegaw","year":"2017","unstructured":"Tsegaw M, Andargie G, Alem G, Tareke M. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia. J Psychiatric Res. 2017;85:37\u201341.","journal-title":"J Psychiatric Res"},{"key":"424_CR29","first-page":"559","volume":"12","author":"M Salahuddin","year":"2020","unstructured":"Salahuddin M, Manzar MD, Hassen HY, Unissa A, Hameed UA, Spence DW, et al. Prevalence and predictors of neurocognitive impairment in Ethiopian population living with HIV. HIV\/AIDS (Auckland, NZ). 2020;12:559.","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"424_CR30","first-page":"425","volume":"13","author":"AD Wubetu","year":"2021","unstructured":"Wubetu AD, Asefa KK, Gebregiorgis BG. Prevalence of neurocognitive impairment and associated factors among people living with HIV on highly active antiretroviral treatment, Ethiopia. HIV\/AIDS (Auckland, NZ). 2021;13:425.","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"424_CR31","doi-asserted-by":"crossref","unstructured":"Yideg Yitbarek G, Mossie Ayana A, Bariso Gare M, Garedew Woldeamanuel G. Prevalence of cognitive impairment and its predictors among HIV\/AIDS patients on antiretroviral therapy in Jimma University medical center, Southwest Ethiopia. Psychiatry J. 2019;2019.","DOI":"10.1155\/2019\/8306823"},{"issue":"19","key":"424_CR32","doi-asserted-by":"publisher","first-page":"e2610","DOI":"10.1212\/WNL.0000000000010752","volume":"95","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu M, Lu Q, Farrell M, Lappin JM, Shi J, et al. Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis. Neurology. 2020;95(19):e2610\u201321.","journal-title":"Neurology"},{"key":"424_CR33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2471\/BLT.13.118422","volume":"91","author":"A Mavrodaris","year":"2013","unstructured":"Mavrodaris A, Powell J, Thorogood M. Prevalences of dementia and cognitive impairment among older people in sub-Saharan Africa: a systematic review. Bull World Health Organ. 2013;91:773\u201383.","journal-title":"Bull World Health Organ"},{"issue":"8","key":"424_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/arclin\/acq079","volume":"25","author":"A Ardila","year":"2010","unstructured":"Ardila A, Bertolucci PH, Braga LW, Castro-Caldas A, Judd T, Kosmidis MH, et al. Illiteracy: the neuropsychology of cognition without reading. Arch Clin Neuropsychol. 2010;25(8):689\u2013712.","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"424_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s13365-012-0141-y","volume":"19","author":"E Weber","year":"2013","unstructured":"Weber E, Morgan EE, Iudicello JE, Blackstone K, Grant I, Ellis RJ, et al. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol. 2013;19(1):65\u201374.","journal-title":"J Neurovirol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00424-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-021-00424-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00424-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T18:05:27Z","timestamp":1639937127000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-021-00424-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1186\/s12981-021-00424-1","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}